164 related articles for article (PubMed ID: 37302808)
1. WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
Li H; Zhang D; Fu Q; Wang S; Zhang X; Lin Z; Wang Z; Song J; Su Z; Xue V; Liu S; Chen Y; Zhou L; Zhao N; Lu D
Cancer Sci; 2023 Aug; 114(8):3318-3329. PubMed ID: 37302808
[TBL] [Abstract][Full Text] [Related]
2. YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia.
Li H; Zhang D; Fu Q; Wang S; Wang Z; Zhang X; Chen X; Zhu X; An N; Chen Y; Zhou L; Lu D; Zhao N
Blood Adv; 2023 Sep; 7(17):4874-4885. PubMed ID: 37339496
[TBL] [Abstract][Full Text] [Related]
3. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
Ling Z; Fang ZG; Wu JY; Liu JJ
Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
[TBL] [Abstract][Full Text] [Related]
4. Sam68 affects cell proliferation and apoptosis of human adult T-acute lymphoblastic leukemia cells via AKT/mTOR signal pathway.
Wang Q; Li Y; Cheng J; Chen L; Xu H; Li Q; Pang T
Leuk Res; 2016 Jul; 46():1-9. PubMed ID: 27107742
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer.
Yuan Y; Qi G; Shen H; Guo A; Cao F; Zhu Y; Xiao C; Chang W; Zheng S
Int J Cancer; 2019 Apr; 144(7):1584-1595. PubMed ID: 29987896
[TBL] [Abstract][Full Text] [Related]
6. Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
Xu W; Wang X; Tu Y; Masaki H; Tanaka S; Onda K; Sugiyama K; Yamada H; Hirano T
Chem Biol Interact; 2019 Sep; 310():108726. PubMed ID: 31255635
[TBL] [Abstract][Full Text] [Related]
7. CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.
Chiang YJ; Liao WT; Ho KC; Wang SH; Chen YG; Ho CL; Huang SF; Shih LY; Yang-Yen HF; Yen JJ
Oncogene; 2019 Feb; 38(9):1432-1447. PubMed ID: 30266989
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways.
Wu KN; Zhao YM; He Y; Wang BS; Du KL; Fu S; Hu KM; Zhang LF; Liu LZ; Hu YX; Wang YJ; Huang H
Leuk Lymphoma; 2014 Mar; 55(3):668-76. PubMed ID: 23741975
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide inhibits growth of human T-cell acute lymphoblastic leukemia Jurkat cells by downregulation of PI3K/AKT and upregulation of p38 MAPK pathways.
Yang T; Yao S; Zhang X; Guo Y
Drug Des Devel Ther; 2016; 10():1389-97. PubMed ID: 27114702
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Xu Y; Li J; Luo Y; Ma J; Huang P; Chen Y; He Z
Biochem Biophys Res Commun; 2023 Jan; 639():150-160. PubMed ID: 36495764
[TBL] [Abstract][Full Text] [Related]
12. Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.
Wang Y; Chen B; Wang Z; Zhang W; Hao K; Chen Y; Li K; Wang T; Xie Y; Huang Z; Tong X
Oncotarget; 2016 Dec; 7(50):82851-82863. PubMed ID: 27756877
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
14. Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.
Guo Y; Shan Q; Gong Y; Lin J; Yang X; Zhou R
Cancer Biol Ther; 2012 Nov; 13(13):1244-54. PubMed ID: 22895079
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
[TBL] [Abstract][Full Text] [Related]
16. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
17. Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.
Tosello V; Saccomani V; Yu J; Bordin F; Amadori A; Piovan E
Oncotarget; 2016 Jul; 7(29):45715-45729. PubMed ID: 27304189
[TBL] [Abstract][Full Text] [Related]
18. Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia.
Yu H; Yin Y; Yi Y; Cheng Z; Kuang W; Li R; Zhong H; Cui Y; Yuan L; Gong F; Wang Z; Li H; Peng H; Zhang G
Cancer Commun (Lond); 2020 Oct; 40(10):501-517. PubMed ID: 32820611
[TBL] [Abstract][Full Text] [Related]
19. Novel Compound, ND-17, Regulates the JAK/STAT, PI3K/AKT, and MAPK Pathways and Restrains Human T-lymphoid Leukemia Development.
Ma W; Liu Y; Lei P; Zhu M; Pan X
Curr Cancer Drug Targets; 2022; 22(5):404-413. PubMed ID: 35249489
[TBL] [Abstract][Full Text] [Related]
20. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
Xiao R; Gan M; Jiang T
Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
